Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Licarbazepine extension in bipolar I mania
NCT00228059Phase 3Completed
- Sponsor
- Novartis
- Start
- Jan 2005
- Primary completion
- Jul 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of licarbazepine in bipolar I disorder, sponsored by Novartis. Started Jan 2005; status: completed.
02
Drugs
licarbazepine
03
Conditions
bipolar I disorder
Beyond the preview
Go deeper on NCT00228059.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00228059.